Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Human Challenge Model Using H3N2
NCT06753474Phase 1Recruiting
- Sponsor
- Emory University
- Start
- Feb 2025
- Primary completion
- Dec 2027
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, open-label trial of influenza a/texas/71/2017 (h3n2)-Duke University in influenza, sponsored by Emory University. Primary endpoints: Number of participants with mild to moderate influenza disease at Day 12, Number of Serious Adverse Events at Week 12 and 1 more. Started Feb 2025; status: recruiting.
02
Drugs
influenza a/texas/71/2017 (h3n2)-Duke University
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06753474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06753474.